Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: eico20 who wrote (1423)	8/11/2015 12:35:06 PM
From: Mirror Image	Read Replies (2) \| Respond to of 2026

It is possible. I would think that they would show actual numbers for quarters that are far behind us ( Q2 14', Q3 14' and even Q4 14' ) versus what we know are estimates like Q2 2015 ( as explained by Pascoe ). Quarterly Units Sold Royalties Received Average Royalty per Unit Sold Q2 14' / Q3 14' = 7,450 Units $36,000 $4.83 Q4 14' = 28,902 Units $88,000 $3.04 Q1 14' = 36,620 Units $75,000 $2.04